Obesity, inflammation, and liver cancer.

[1]  T. Kourelis,et al.  Metformin and cancer: new applications for an old drug , 2012, Medical Oncology.

[2]  Michael Karin,et al.  Inflammation meets cancer, with NF-κB as the matchmaker , 2011, Nature Immunology.

[3]  Keiji Tanaka,et al.  Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells , 2011, The Journal of cell biology.

[4]  Y. Eishi,et al.  Autophagy-deficient mice develop multiple liver tumors. , 2011, Genes & development.

[5]  P. Vandenabeele,et al.  Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality , 2011, Cell Death and Differentiation.

[6]  M. Czaja,et al.  Autophagy in nonalcoholic steatohepatitis , 2011, Expert review of gastroenterology & hepatology.

[7]  S. Yamasaki,et al.  Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis , 2011, Rheumatology International.

[8]  G. Saggese,et al.  Nuclear damage in peripheral lymphocytes of obese and overweight Italian children as evaluated by the γ‐H2AX focus assay and micronucleus test , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  I. Weissman,et al.  IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ , 2011, Nature Immunology.

[10]  B. Viollet,et al.  Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy , 2011, Science.

[11]  Meei-Shyuan Lee,et al.  Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals , 2011, BMC Cancer.

[12]  S. Gaffen,et al.  IL-17 in obesity and adipogenesis. , 2010, Cytokine & growth factor reviews.

[13]  R. Moreau,et al.  Autophagy in liver diseases. , 2010, Journal of hepatology.

[14]  F. Anania,et al.  Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. , 2010, Gastroenterology.

[15]  C. Bortner,et al.  Nuclear Orphan Receptor TAK1/TR4-Deficient Mice Are Protected Against Obesity-Linked Inflammation, Hepatic Steatosis, and Insulin Resistance , 2010, Diabetes.

[16]  D. V. van Thiel,et al.  Non-Viral Causes of Hepatocellular Carcinoma , 2010, Journal of gastrointestinal cancer.

[17]  Ashley M. Miller,et al.  Interleukin-33 Induces Protective Effects in Adipose Tissue Inflammation During Obesity in Mice , 2010, Circulation research.

[18]  A. Rudich,et al.  Interleukin-1beta may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation. , 2010, Endocrinology.

[19]  M. Karin,et al.  JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Yuichi Akasaki,et al.  Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity , 2010, Science.

[21]  K. Clément,et al.  Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. , 2010, The Journal of clinical endocrinology and metabolism.

[22]  S. Harrison,et al.  Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.

[23]  T. Johansen,et al.  Selective autophagy in cancer development and therapy. , 2010, Cancer research.

[24]  G. Zanette,et al.  Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[25]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[26]  G. Hotamisligil,et al.  Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease , 2010, Cell.

[27]  M. Karin,et al.  Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. , 2010, Cancer cell.

[28]  D. Sargent,et al.  Obesity Is an Independent Prognostic Variable in Colon Cancer Survivors , 2010, Clinical Cancer Research.

[29]  S. Friedman,et al.  Obesity, inflammatory signaling, and hepatocellular carcinoma-an enlarging link. , 2010, Cancer cell.

[30]  Jun Hee Lee,et al.  Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.

[31]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.

[32]  A. Chervonsky,et al.  Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. , 2010, The Journal of clinical investigation.

[33]  S. Akira,et al.  Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis , 2009, Proceedings of the National Academy of Sciences.

[34]  B. Bowman,et al.  Obesity and Endometrial Cancer: Challenges for Public Health Action , 2009, Women's health.

[35]  D. Sabatini,et al.  mTOR signaling at a glance , 2009, Journal of Cell Science.

[36]  T. Kadowaki,et al.  Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis , 2009, Journal of gastroenterology and hepatology.

[37]  A. Jasińska,et al.  Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH). , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[38]  E. Chan,et al.  mTORC1 Phosphorylates the ULK1-mAtg13-FIP200 Autophagy Regulatory Complex , 2009, Science Signaling.

[39]  T. Kadowaki,et al.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity , 2009, Nature Medicine.

[40]  R. Nagai,et al.  Adipose tissue inflammation in obesity and metabolic syndrome. , 2009, Discovery medicine.

[41]  D. Sabatini,et al.  mTOR Mediated Anti-Cancer Drug Discovery. , 2009, Drug discovery today. Therapeutic strategies.

[42]  R. Marfella,et al.  Effect of weight loss on coronary circulation and adiponectin levels in obese women. , 2009, International journal of cardiology.

[43]  M. Czaja,et al.  Autophagy regulates lipid metabolism , 2009, Nature.

[44]  K. Eriksson,et al.  Nonalcoholic steatohepatitis in obesity: a reversible condition. , 2009, Acta medica Scandinavica.

[45]  G. Tarantino,et al.  Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? , 2009, Journal of Inflammation.

[46]  J. Elmquist,et al.  From observation to experimentation: leptin action in the mediobasal hypothalamus. , 2009, The American journal of clinical nutrition.

[47]  Jun-Fen Fu,et al.  A rabbit model of pediatric nonalcoholic steatohepatitis: the role of adiponectin. , 2009, World journal of gastroenterology.

[48]  G. Treiber.  mTOR inhibitors for hepatocellular cancer: a forward-moving target , 2009, Expert review of anticancer therapy.

[49]  R. Russell,et al.  Nonalcoholic steatohepatitis induced by a high‐fat diet promotes diethylnitrosamine‐initiated early hepatocarcinogenesis in rats , 2009, International journal of cancer.

[50]  M. Taniai,et al.  Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis , 2009, Journal of Gastroenterology.

[51]  M. Czaja,et al.  Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance , 2009, Hepatology.

[52]  A. Mora,et al.  A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance , 2008, Science.

[53]  Ping Chen,et al.  Pharmacological characterization of a small molecule inhibitor of c-Jun kinase. , 2008, American Journal of Physiology. Endocrinology and Metabolism.

[54]  D. Klionsky,et al.  How to live long and prosper: autophagy, mitochondria, and aging. , 2008, Physiology.

[55]  B. Asselain,et al.  Is obesity an independent prognosis factor in woman breast cancer? , 2008, Breast Cancer Research and Treatment.

[56]  Gary Hardiman,et al.  Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. , 2008, Cancer cell.

[57]  Chien-Jen Chen,et al.  Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. , 2008, Gastroenterology.

[58]  J. Dufour,et al.  Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma. , 2008, Journal of hepatology.

[59]  A. La Cava,et al.  Leptin and Inflammation. , 2008, Current immunology reviews.

[60]  T. Luedde,et al.  Hepatic NF-κB essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis , 2008, Proceedings of the National Academy of Sciences.

[61]  A. Baranova,et al.  Adipokines and cytokines in non‐alcoholic fatty liver disease , 2007, Alimentary pharmacology & therapeutics.

[62]  M. Karin,et al.  JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. , 2007, Cell metabolism.

[63]  D. Hardie,et al.  AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy , 2007, Nature Reviews Molecular Cell Biology.

[64]  G. Bjørkøy,et al.  p62/SQSTM1 Binds Directly to Atg8/LC3 to Facilitate Degradation of Ubiquitinated Protein Aggregates by Autophagy* , 2007, Journal of Biological Chemistry.

[65]  S. Nishimura,et al.  TAK1 represses transcription of the human telomerase reverse transcriptase gene , 2007, Oncogene.

[66]  E. White,et al.  Autophagy suppresses tumor progression by limiting chromosomal instability. , 2007, Genes & development.

[67]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[68]  Christian Haslinger,et al.  p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway , 2007, Nature Genetics.

[69]  P. Froguel,et al.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.

[70]  T. Luedde,et al.  Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma , 2007 .

[71]  K. Choi,et al.  Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. , 2007, Diabetes research and clinical practice.

[72]  A. Sinaiko,et al.  Obesity and inflammation in children. , 2006, Paediatric respiratory reviews.

[73]  M. Karin,et al.  Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates , 2006, Proceedings of the National Academy of Sciences.

[74]  M. Bougoulia,et al.  Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women. , 2006, Hormones.

[75]  D. Hardie.  Neither LKB1 nor AMPK are the direct targets of metformin. , 2006, Gastroenterology.

[76]  S. Khalifé,et al.  Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. , 2006, European journal of endocrinology.

[77]  L. Bernstein,et al.  Effects of etanercept in patients with the metabolic syndrome. , 2006, Archives of internal medicine.

[78]  M. Czaja,et al.  Jnk1 but not jnk2 promotes the development of steatohepatitis in mice , 2006, Hepatology.

[79]  P. Scherer,et al.  Keynote review: the adipocyte as a drug discovery target. , 2005, Drug discovery today.

[80]  R. Mooney,et al.  Interleukin-6 depletion selectively improves hepatic insulin action in obesity. , 2005, Endocrinology.

[81]  Michael Karin,et al.  IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis , 2005, Cell.

[82]  G. Fantuzzi.  Adipose tissue, adipokines, and inflammation. , 2005, The Journal of allergy and clinical immunology.

[83]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[84]  R. Pratley,et al.  The evolving role of inflammation in obesity and the metabolic syndrome , 2005, Current diabetes reports.

[85]  S. Caldwell,et al.  Obesity and hepatocellular carcinoma. , 2004, Gastroenterology.

[86]  Jian-Min Yuan,et al.  Environmental factors and risk for hepatocellular carcinoma. , 2004, Gastroenterology.

[87]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[88]  T. Reinehr,et al.  Adiponectin before and after weight loss in obese children. , 2004, The Journal of clinical endocrinology and metabolism.

[89]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[90]  K. Flegal,et al.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. , 2004, JAMA.

[91]  E. Abdalla,et al.  Obesity and diabetes as a risk factor for hepatocellular carcinoma , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[92]  K. Rajewsky,et al.  Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance , 2004 .

[93]  K. Inoki,et al.  TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.

[94]  T. Zimmers,et al.  Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. , 2003, Diabetes.

[95]  T. Kitamura,et al.  Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. , 2003, Experimental hematology.

[96]  M. Karin,et al.  IKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα , 2003 .

[97]  A. Shirahata,et al.  Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. , 2003, Obesity research.

[98]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[99]  Arya M. Sharma,et al.  Association between adiponectin and mediators of inflammation in obese women. , 2003, Diabetes.

[100]  R. Mooney,et al.  Interleukin-6 induces cellular insulin resistance in hepatocytes. , 2002, Diabetes.

[101]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[102]  S Margetic,et al.  Leptin: a review of its peripheral actions and interactions , 2002, International Journal of Obesity.

[103]  Katherine M Flegal,et al.  Prevalence and trends in overweight among US children and adolescents, 1999-2000. , 2002, JAMA.

[104]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[105]  D. Hardie,et al.  The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. , 2002, Diabetes.

[106]  G. Loss,et al.  Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? , 2002, Hepatology.

[107]  E. Jéquier.  Leptin Signaling, Adiposity, and Energy Balance , 2002, Annals of the New York Academy of Sciences.

[108]  W. Rathmann,et al.  Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors , 2002, Diabetologia.

[109]  A. Rocchini,et al.  Childhood obesity and a diabetes epidemic. , 2002, The New England journal of medicine.

[110]  C. Stehouwer,et al.  Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. , 2002, Atherosclerosis.

[111]  R. Faggioni,et al.  Leptin regulation of the immune response and the immunodeficiency of malnutrition 1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[112]  M. Borkenstein,et al.  Changes in serum interleukin-6 concentrations in obese children and adolescents during a weight reduction program , 2001, International Journal of Obesity.

[113]  J. Beattie,et al.  Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ , 2001, Proceedings of the Nutrition Society.

[114]  V. P. Chacko,et al.  Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? , 2001, Cancer research.

[115]  B. Richelsen,et al.  Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. , 2001, The Journal of clinical endocrinology and metabolism.

[116]  P. Trayhurn,et al.  Regulation of leptin production: sympathetic nervous system interactions , 2001, Journal of Molecular Medicine.

[117]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[118]  B Järvholm,et al.  Obesity, hypertension, and the risk of kidney cancer in men. , 2000, The New England journal of medicine.

[119]  J. P. Adams,et al.  Obesity in anaesthesia and intensive care. , 2000, British journal of anaesthesia.

[120]  M. Visser,et al.  Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.

[121]  A. Bado,et al.  The stomach is a source of leptin , 1998, Nature.

[122]  J. Pickup,et al.  NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X , 1997, Diabetologia.

[123]  U. Rüther,et al.  Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. , 1997, The Biochemical journal.

[124]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.

[125]  J. Auwerx,et al.  The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. , 1996, The Journal of clinical investigation.

[126]  Roy Taylor,et al.  Effects of an Engineered Human Anti–TNF-α Antibody (CDP571) on Insulin Sensitivity and Glycemic Control in Patients With NIDDM , 1996, Diabetes.

[127]  T. Funahashi,et al.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.

[128]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[129]  M. Pelleymounter,et al.  Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.

[130]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[131]  J. Friedman,et al.  Molecular mapping of the mouse ob mutation. , 1991, Genomics.

[132]  I. Wanless,et al.  Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors , 1990, Hepatology.

[133]  P. Heinrich,et al.  Acute‐phase response of human hepatocytes: Regulation of acute‐phase protein synthesis by interleukin‐6 , 1990, Hepatology.

[134]  G. Lyman,et al.  Abdominal obesity and breast cancer risk. , 1990, Annals of internal medicine.

[135]  B. Aggarwal,et al.  Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[136]  S. Sakaguchi,et al.  Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress. , 2011, Drug metabolism and pharmacokinetics.

[137]  F. Sinicrope,et al.  Obesity and breast cancer prognosis: weight of the evidence. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[138]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[139]  A. Diehl.  Hepatic complications of obesity. , 2010, Gastroenterology clinics of North America.

[140]  A. Jasińska,et al.  ADIPOHORMONES AS PROGNOSTIC MARKERS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) , 2009 .

[141]  C. Day,et al.  Non-alcoholic fatty liver disease: the mist gradually clears. , 2008, Journal of hepatology.

[142]  T. Luedde,et al.  Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. , 2007, Cancer cell.

[143]  M. Neuenhahn,et al.  NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. , 2007, Cell.

[144]  Kok Weng Chan,et al.  POSTTRANSLATIONAL MODIFICATIONS ON THE FOUR CONSERVED LYSINE RESIDUES WITHIN THE COLLAGENOUS DOMAIN OF ADIPONECTIN ARE REQUIRED FOR THE FORMATION OF ITS HIGH-MOLECULAR-WEIGHT OLIGOMERIC COMPLEX , 2006 .

[145]  A. Hevener,et al.  IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.

[146]  K. Inoki,et al.  TSC2: filling the GAP in the mTOR signaling pathway. , 2004, Trends in biochemical sciences.

[147]  G. Thomas,et al.  The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb. , 2004, Novartis Foundation symposium.

[148]  K. Rajewsky,et al.  Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance. , 2004, The Journal of clinical investigation.

[149]  M. Karin,et al.  IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha. , 2003, Immunity.

[150]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[151]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[152]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. , 1997, Nature.

[153]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[154]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[155]  M. Dickie,et al.  Obese, a new mutation in the house mouse. , 1950, The Journal of heredity.